Navigation Links
American Pacific Reports Fiscal 2011 Results
Date:12/14/2011

Share  As Adjusted 

$
4,352

$
2,235

$
.30 Remediation Charges 

(6,000)

(3,600)

(0.48) Other Operating Gains 

2,929

1,757

0.23 Deferred Tax Asset Valuation Allowance 

-

(7,628)

(1.01) As Reported 

$
,281

$
(7,236)

$
(0.96) 

 

 

 Quarter Ended September 30, 2011 Compared to Quarter Ended September 30, 2010

  • Revenues increased to $80.7 million from $45.5 million.
  • Operating income increased to $19.1 million compared to $4.7 million.
  • Adjusted EBITDA was $23.0 million compared to $9.9 million.
  • Adjusted Net Income was $11.4 million compared to net income of $1.6 million.
  • Adjusted Diluted Earnings per share was $1.50 compared to diluted earnings per share of $0.22.
  • The following table reconciles each of the adjusted Fiscal 2011 fourth quarter results to the most directly comparable GAAP measure (dollars in thousands except per share amounts).

     

     

     

     Diluted  

     

     

     Earnings  

     

     Net Income 

     Per Share  As Adjusted 

     

    $
    ,388

    $
    .50 Deferred Tax Asset Valuation Allowance 

     

    (7,628)

    (1.01) As Reported 

     

    $
    3,760

    $
    .49 

     

     

      

    CONSOLIDATED RESULTS OF OPERATIONSRevenuesFor Fiscal 2011, revenues increased 19% to $209.7 million as compared to Fiscal 2010, reflecting increases in Fine Chemicals segment revenues of 29%, Specialty Chemicals segment revenues of 7% and Aerospace E
    '/>"/>

    SOURCE American Pacific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
    3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
    4. Aspirin Named 8th World Wonder by Majority of Americans
    5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
    6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
    7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
    8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
    9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
    10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
    11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/1/2015)...  Philips Respironics, a division of Royal Philips ... Pico nasal mask is now available in ... sleep apnea (OSA). Designed to maximize comfort and effectiveness, Pico ... (CPAP) mask available on the market to treat OSA*. Philips ... be on display at Medtrade Spring (Booth #235) ...
    (Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
    (Date:4/1/2015)... Quebec , April 1, 2015 ... (NYSE: VRX and TSX: ... the previously announced acquisition of Salix ... specialty pharmaceutical company that offers innovative ... 550 mg, RUCONEST ®  (C1 esterase inhibitor [recombinant]), APRISO ...
    Breaking Medicine Technology:Philips Pico CPAP Nasal Mask Now Available in the United States 2Philips Pico CPAP Nasal Mask Now Available in the United States 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
    ... 11 Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company ... for the treatment of antibiotic-resistant infections, will present pre-clinical ... Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is ... 15, 2009. The presentations will include comprehensive ...
    ... , BURLINGTON, Mass., Sept. 11 ... the Cardiovascular Research Foundation,s (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) ... 25th, in San Francisco, CA. at the Moscone Center. This ... those performing cardiac diagnostics and interventions. , , ...
    Cached Medicine Technology:Calixa Therapeutics to Make Multiple Presentations on CXA-101 and CXA-101/tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Calixa Therapeutics to Make Multiple Presentations on CXA-101 and CXA-101/tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Calixa Therapeutics to Make Multiple Presentations on CXA-101 and CXA-101/tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting 2
    (Date:4/2/2015)... Atlanta-based Kanga, the first SaaS-based platform ... Best Start Up in Atlanta by General Assembly Atlanta. ... Calend.ly, GottaGolf, LOV, Ticket Alternative, and TripTap. T General ... of over 500 at their Atlanta Launch Party at ... and mobile platform for initiating, managing and tracking last ...
    (Date:4/1/2015)... April 02, 2015 Robins & Morton ... Living Media Services Building for the New T-Mobile Financial ... five months, including complete demolition of the interior systems, ... addition of 250 parking spaces to accommodate employees. ... his firm was excited to develop such a unique ...
    (Date:4/1/2015)... Glen Mills, PA - Holganix LLC ... Healthy Grow fertilizer line to produce an organic-based granular ... manufactures a line of organic bionutritional products that contain ... plant, turf and tree health. Pearl Valley Farms is ... a manufacturer of organic fertilizers. , Healthy Grow ...
    (Date:4/1/2015)... Awareness Month , The National Council on Alcoholism and ... Month every April since 1987. Its purpose is ... issues. During the month of April, NCADD encourages ... For the Health of It: Early Education on Alcoholism ... Month. During April, focus is on the issues ...
    (Date:4/1/2015)... Freeport, ME (PRWEB) April 01, 2015 Royal ... Freeport, Maine, reports a new study that found the amino ... speed, also improved circulation by lowering blood pressure. , The ... of “ Natural Insights for Well Being® ,” which Royal ... for Freeport friends and neighbors to learn the latest in ...
    Breaking Medicine News(10 mins):Health News:Kanga Wins Best Start Up in Atlanta 2Health News:Robins & Morton Transforms Former Southern Living Media Services Building for New T-Mobile Financial Care Call Center 2Health News:Holganix Expands Its Organic Turf Portfolio Success by Partnering with Pearl Valley Farms to Produce an Organic-Based Granular Fertilizer 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 3Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2
    ... , , , ... care from the top down, Regence was recognized for its work ... , , "Transforming the Health Care System - ... Gard Communications of Portland, won awards from Summit International and from ...
    ... , , SCHAUMBURG, Ill., July ... International Agency for Research on Cancer (IARC) for its re-categorization ... places indoor tanning in the highest cancer risk category afforded ... World Health Organization (WHO). , , ...
    ... serious complications 4.3 percent, , WEDNESDAY, July 29 (HealthDay ... significant obesity, a new study suggests the risk of ... been reported. , The study, which looked at both ... surgery), found that the risk of death for these ...
    ... ... Press Conference on New Study , ... Philadelphia, PA (Vocus) July 29, 2009 -- A groundbreaking study in Cancer Prevention ... human papillomavirus (HPV) improves survival in squamous cell carcinoma of the head and neck. Furthermore, ...
    ... , , ST. LOUIS, July 29 ... quarter net income from continuing operations of $192.0 million, or $0.74 ... related to the previously announced acquisition of WellPoint,s pharmacy benefit management ... $0.76 for the same period last year. These earnings for the ...
    ... , PRINCETON, N.J., July 29 ... for its second quarter ended June 30, 2009 of $0.67 per ... the sale of its centralized ECG business in 2007. Excluding the ... , "On a consolidated basis, second quarter net revenues ...
    Cached Medicine News:Health News:Regence Wins Awards for Consumer Appeal to Transform Health Care 2Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 2Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 3Health News:Study Finds Weight-Loss Surgery Safer Than Thought 2Health News:Study Finds Weight-Loss Surgery Safer Than Thought 3Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 2Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 3Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 4Health News:Express Scripts Reports Strong Second Quarter Earnings 2Health News:Express Scripts Reports Strong Second Quarter Earnings 3Health News:Express Scripts Reports Strong Second Quarter Earnings 4Health News:Express Scripts Reports Strong Second Quarter Earnings 5Health News:Express Scripts Reports Strong Second Quarter Earnings 6Health News:Express Scripts Reports Strong Second Quarter Earnings 7Health News:Express Scripts Reports Strong Second Quarter Earnings 8Health News:Express Scripts Reports Strong Second Quarter Earnings 9Health News:Express Scripts Reports Strong Second Quarter Earnings 10Health News:Express Scripts Reports Strong Second Quarter Earnings 11Health News:Express Scripts Reports Strong Second Quarter Earnings 12Health News:Express Scripts Reports Strong Second Quarter Earnings 13Health News:Express Scripts Reports Strong Second Quarter Earnings 14Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 2Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 3Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 4Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 5Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 6Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 7Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 8Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 9Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 10Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 11Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 12Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 13
    ... Advia 120 hematology system ... laboratory workflow and achieve ... analyzer offers a unique ... meeting the needs of ...
    The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
    AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
    MAXM is a reliable benchtop solution for processing mid-size volume workloads. Features include three-dimensional VCS technology, continuous autoloading and easy-to-use data management capabilities....
    Medicine Products: